Coeptis Therapeutics Stock (NASDAQ: COEP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 463.08K |
Day Range | - - - |
52 Wk Range | 0.23 - 1.41 |
Market Cap | $10.50M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.31% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.
Other companies in Coeptis Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN) and Lumos Pharma (NASDAQ:LUMO).
There is no analysis for Coeptis Therapeutics.
Coeptis Therapeutics has a consensus price target of $5.67.
The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $0.283 last updated July 19, 2024 at 4:44 PM EDT.
There are no upcoming dividends for Coeptis Therapeutics.
Coeptis Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Coeptis Therapeutics.
Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.